NRP1指导IL-17-产生ILC3s驱动大肠炎的进展
Ying Wang1,2,3, Jianye Wang1,2, Gaoyu Liu1,2,4
1Department of oncology, The Second Hospital of Tianjin Medical University; Tianjin Key Laboratory of Precision Medicine for Sex Hormones and Diseases; Tianjin Institute of Immunology, Department of Immunology, School of Basic Medical Sciences, Tianjin Medical University, Tianjin, China.
Cellular & molecular immunology
|December 31, 2024
概括
神经皮林-1 (NRP1) 促进了肠道3组先天性淋巴细胞 (ILC3) 产生的互白素-17 (IL-17) 的产生. 抑制NRP1可以减少炎症性肠病 (IBD) 模型中的炎症,这表明NRP1是治疗点.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 细胞生物学 细胞生物学
背景情况:
- 第三组先天性淋巴细胞 (ILC3s) 对于维持肠道平衡和调节粘膜炎症至关重要.
- 控制ILC3功能的特定分子机制,特别是在炎症性肠病 (IBD) 的背景下,仍然不完全理解.
研究的目的:
- 为了确定肠道ILC3活性的新型调节剂.
- 研究神经皮林-1 (NRP1) 在ILC3功能中的作用及其作为IBD治疗点的潜力.
主要方法:
- 来自IBD患者和健康对照的肠粘膜活检的分析.
- 遗传缺陷模型评估NRP1对ILC3频率和IL-17A产生的影响.
- 在体内研究使用德克斯硫酸盐 (DSS) 诱导的大肠炎模型.
- 使用EG00229.9进行NRP1的药理抑制.
主要成果:
- 发现神经素-1 (NRP1) 在IBD患者的肠道组织中显著上调.
- NRP1的遗传缺陷导致ILC3的数量减少,并以细胞内在的,依赖NF-κB的方式损害IL-17A的产生.
- 通过ILC3s减少IL-17A的产生改变了肠道微生物群的组成,并改善了DSS诱导的大肠炎.
- 用EG00229药理抑制NRP1有效降低了结肠炎的严重程度.
结论:
- 神经皮林-1 (NRP1) 作为肠道IL-17-产生ILLC3的关键正调节剂.
- NRP1在肠道炎症的发病过程中起着至关重要的作用.
- 针对NRP1是一个有前途的治疗策略,用于管理炎症性肠病 (IBD).
相关概念视频
T Cell Types and Functions
946
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
946
Renewal of Intestinal Stem Cells
2.5K
The intestinal epithelial lining rapidly renews every 4 to 5 days. The renewal is facilitated by intestinal stem cells (ISCs) located at the base of the crypt– a gland located at the bottom of each villus. ISCs divide asymmetrically to form new stem cells and progenitor daughter cells. The daughter cells are called transit-amplifying (TA) cells which move upwards along the crypt and either differentiate into absorptive cells– the enterocytes or secretory cells– including the...
2.5K


